Sánchez P, Bosch R J, de Gálvez M V, Rodrigo A B, Herrera E
Dermatology Department, Faculty of Medicine, Málaga University, Málaga, Spain.
Int J STD AIDS. 2001 Oct;12(10):687-9. doi: 10.1258/0956462011923804.
We report a case of mucocutaneous leishmaniasis (MCL) in a patient with the human immunodeficiency virus (HIV), Centers for Disease Control (CDC) Stage A2, with no previous history of cutaneous or systemic leishmaniasis. The patient had not travelled outside the province of Málaga, on the Mediterranean coast of southern Spain, so that it concerns an indigenous case, extremely unusual in this area. The HIV infection may well have influenced the defence against leishmania, but the exact mechanism by which this occurred is unknown.
